Oncotarget · 2018 · 44 citations · 61 references
MedicineGeneticsOncologyCarcinogenesisEpigeneticsMolecular OncologyCancer EpigeneticsColorectal CancerEpigenetic Alterations In CancerEpigenetic Regulation In CancerTumor Suppressor Gene InactivationTumor Suppressor GenesDna HydroxymethylationEpigenetic Alterations In CarcinogenesisEpigenetic Gene SilencingEpigenetic SilencingEpigenetic Silencing Of Tumor Suppressor GenesEpigenetic Targeted AgentsTumor Suppressor Gene HypermethylationTumor Suppressor Gene Methylation
// Christian Gerecke 1 , Fabian Schumacher 1, 2 , Alexander Edlich 1 , Alexandra Wetzel 1 , Guy Yealland 1 , Lena Katharina Neubert 1 , Bettina Scholtka 1 , Thomas Homann 1 and Burkhard Kleuser 1, 3 1 Institute of Nutritional Science, Department of Nutritional Toxicology, University of Potsdam, Nuthetal, Germany 2 Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany 3 NutriAct – Competence Cluster Nutrition Research Berlin-Potsdam, Germany Correspondence to: Burkhard Kleuser, email: kleuser@uni-potsdam.de Keywords: vitamin C; tumor suppressors; epigenetics; TET; DNA hydroxymethylation Received: May 16, 2018 Accepted: August 04, 2018 Published: August 28, 2018 ABSTRACT Epigenetic silencing of tumour suppressor genes is a key hallmark of colorectal carcinogenesis. Despite this, the therapeutic potential of epigenetic agents capable of reactivating these silenced genes remains relatively unexplored. Evidence has shown the dietary antioxidant vitamin C (ascorbate) acts as an inducer of the ten-eleven translocation (TET) dioxygenases, an enzyme family that catalyses a recently described mechanism of DNA demethylation linked to gene re-expression. In this study, we set out to determine whether vitamin C can enhance the known anti-neoplastic actions of the DNA-demethylating agents decitabine (DAC) and azacytidine (AZA) in colorectal cancer cells. Administration of vitamin C alone significantly enhanced global levels of 5-hydroxymethyl-2’-deoxycytidine (5-hmdC), without altering 5-methyl-2’-deoxycytidine (5-mdC), as would be expected upon the activation of TET dioxygenases. Concomitant treatment of vitamin C with either AZA or DAC resulted in an unexpectedly high increase of global 5-hmdC levels, one that administration of any these compounds alone could not achieve. Notably, this was also accompanied by increased expression of the tumour suppressor p21 (CDKN1A) , and a significant increase in apoptotic cell induction. Our in vitro data leads us to hypothesize that the reactivation of genes in colorectal cancer cells by AZA or DAC can be improved when the 5-hmdC levels are simultaneously increased by the TET activator vitamin C. The dual administration of demethylating agents and vitamin C to colorectal cancer patients, a demographic in which vitamin C deficiencies are common, may improve responses to epigenetic therapies.
61
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani, Kian Peng Koh, Yinghua Shen et al. · Science · 2009 · 5.8K citations · Full text
Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold, Mónica S. Sierra, Mathieu Laversanne et al. · Gut · 2016 · 5.3K citations · Full text
Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine
Shinsuke Ito, Li Shen, Qing Dai et al. · Science · 2011 · 3.4K citations
Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA
Yufei He, Bin-Zhong Li, Zheng Li et al. · Science · 2011 · 2.8K citations
Pierre Fenaux, Ghulam J. Mufti, Eva Hellström‐Lindberg et al. · The Lancet Oncology · 2009 · 2.6K citations · Full text